Stephen K. Austin, Ph.D. - Publications

2012 Biology & Biomedical Sciences (Immunology) Washington University, Saint Louis, St. Louis, MO 
Immunology, Virology Biology, General Biophysics

28 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Austin SK, Kavakli K, Norton M, Peyvandi F, Shapiro A. Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in subjects with hereditary factor X deficiency. Haemophilia : the Official Journal of the World Federation of Hemophilia. 22: 419-25. PMID 27197801 DOI: 10.1111/hae.12893  0.32
2016 Austin SK, Brindley C, Kavakli K, Norton M, Shapiro A. Pharmacokinetics of a high-purity plasma-derived factor X concentrate in subjects with moderate or severe hereditary factor X deficiency Haemophilia. DOI: 10.1111/hae.12894  0.32
2015 Long F, Fong RH, Austin SK, Chen Z, Klose T, Fokine A, Liu Y, Porta J, Sapparapu G, Akahata W, Doranz BJ, Crowe JE, Diamond MS, Rossmann MG. Cryo-EM structures elucidate neutralizing mechanisms of anti-chikungunya human monoclonal antibodies with therapeutic activity. Proceedings of the National Academy of Sciences of the United States of America. PMID 26504196 DOI: 10.1073/Pnas.1515558112  0.01
2015 Batty P, Honke A, Bowles L, Hart DP, Pasi KJ, Uprichard J, Austin SK. Ongoing risk of thrombosis with factor XI concentrate: 5 years experience in two centres. Haemophilia : the Official Journal of the World Federation of Hemophilia. 21: 490-5. PMID 25855341 DOI: 10.1111/hae.12682  0.01
2014 Oldenburg J, Austin SK, Kessler CM. ITI choice for the optimal management of inhibitor patients - from a clinical and pharmacoeconomic perspective Haemophilia. 20: 17-26. PMID 24975701 DOI: 10.1111/hae.12466  0.32
2014 Edeling MA, Austin SK, Shrestha B, Dowd KA, Mukherjee S, Nelson CA, Johnson S, Mabila MN, Christian EA, Rucker J, Pierson TC, Diamond MS, Fremont DH. Potent dengue virus neutralization by a therapeutic antibody with low monovalent affinity requires bivalent engagement. Plos Pathogens. 10: e1004072. PMID 24743696 DOI: 10.1371/Journal.Ppat.1004072  0.32
2014 Patel YM, Lordkipanidzé M, Lowe GC, Nisar SP, Garner K, Stockley J, Daly ME, Mitchell M, Watson SP, Austin SK, Mundell SJ. A novel mutation in the P2Y12 receptor and a function-reducing polymorphism in protease-activated receptor 1 in a patient with chronic bleeding. Journal of Thrombosis and Haemostasis : Jth. 12: 716-25. PMID 24612435 DOI: 10.1111/Jth.12539  0.32
2014 van Hecke O, Austin SK, Khan RA, Smith BH, Torrance N. Neuropathic pain in the general population: a systematic review of epidemiological studies. Pain. 155: 654-62. PMID 24291734 DOI: 10.1016/j.pain.2013.11.013  0.01
2013 Smith SA, de Alwis AR, Kose N, Harris E, Ibarra KD, Kahle KM, Pfaff JM, Xiang X, Doranz BJ, de Silva AM, Austin SK, Sukupolvi-Petty S, Diamond MS, Crowe JE. The potent and broadly neutralizing human dengue virus-specific monoclonal antibody 1C19 reveals a unique cross-reactive epitope on the bc loop of domain II of the envelope protein. Mbio. 4: e00873-13. PMID 24255124 DOI: 10.1128/Mbio.00873-13  0.32
2013 Lee PD, Mukherjee S, Edeling MA, Dowd KA, Austin SK, Manhart CJ, Diamond MS, Fremont DH, Pierson TC. The Fc region of an antibody impacts the neutralization of West Nile viruses in different maturation states. Journal of Virology. 87: 13729-40. PMID 24109224 DOI: 10.1128/Jvi.02340-13  0.32
2013 Sukupolvi-Petty S, Brien JD, Austin SK, Shrestha B, Swayne S, Kahle K, Doranz BJ, Johnson S, Pierson TC, Fremont DH, Diamond MS. Functional analysis of antibodies against dengue virus type 4 reveals strain-dependent epitope exposure that impacts neutralization and protection. Journal of Virology. 87: 8826-42. PMID 23785205 DOI: 10.1128/Jvi.01314-13  0.32
2013 Zhou Y, Austin SK, Fremont DH, Yount BL, Huynh JP, de Silva AM, Baric RS, Messer WB. The mechanism of differential neutralization of dengue serotype 3 strains by monoclonal antibody 8A1 Virology. 439: 57-64. PMID 23453578 DOI: 10.1016/J.Virol.2013.01.022  0.32
2013 Doherty T, Austin SK, Newell B, Kiely PDW. Mycophenolate mofetil-induced erythroid hypoplasia in a patient with systemic lupus erythematosus Lupus. 22: 213-215. PMID 23257406 DOI: 10.1177/0961203312469262  0.32
2013 McDonald V, Austin SK. Inherited bleeding disorders Medicine (United Kingdom). 41: 231-233. DOI: 10.1016/j.mpmed.2013.01.014  0.32
2012 Austin SK, Dowd KA, Shrestha B, Nelson CA, Edeling MA, Johnson S, Pierson TC, Diamond MS, Fremont DH. Structural basis of differential neutralization of DENV-1 genotypes by an antibody that recognizes a cryptic epitope. Plos Pathogens. 8: e1002930. PMID 23055922 DOI: 10.1371/Journal.Ppat.1002930  0.32
2012 Shrestha B, Austin SK, Dowd KA, Prasad AN, Youn S, Pierson TC, Fremont DH, Ebel GD, Diamond MS. Complex phenotypes in mosquitoes and mice associated with neutralization escape of a Dengue virus type 1 monoclonal antibody. Virology. 427: 127-34. PMID 22406169 DOI: 10.1016/J.Virol.2012.02.010  0.32
2010 Brien JD, Austin SK, Sukupolvi-Petty S, O'Brien KM, Johnson S, Fremont DH, Diamond MS. Genotype-specific neutralization and protection by antibodies against dengue virus type 3. Journal of Virology. 84: 10630-43. PMID 20702644 DOI: 10.1128/Jvi.01190-10  0.32
2010 Sukupolvi-Petty S, Austin SK, Engle M, Brien JD, Dowd KA, Williams KL, Johnson S, Rico-Hesse R, Harris E, Pierson TC, Fremont DH, Diamond MS. Structure and function analysis of therapeutic monoclonal antibodies against dengue virus type 2. Journal of Virology. 84: 9227-39. PMID 20592088 DOI: 10.1128/Jvi.01087-10  0.32
2010 Shrestha B, Brien JD, Sukupolvi-Petty S, Austin SK, Edeling MA, Kim T, O'Brien KM, Nelson CA, Johnson S, Fremont DH, Diamond MS. The development of therapeutic antibodies that neutralize homologous and heterologous genotypes of dengue virus type 1. Plos Pathogens. 6: e1000823. PMID 20369024 DOI: 10.1371/Journal.Ppat.1000823  0.32
2009 Vogt MR, Moesker B, Goudsmit J, Jongeneelen M, Austin SK, Oliphant T, Nelson S, Pierson TC, Wilschut J, Throsby M, Diamond MS. Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step. Journal of Virology. 83: 6494-507. PMID 19386704 DOI: 10.1128/Jvi.00286-09  0.32
2009 Austin SK. Haemostasis Medicine. 37: 133-136. DOI: 10.1016/j.mpmed.2009.01.015  0.32
2008 Lambert JR, Austin SK, Peebles D, Cohen H. Audit of the peri-delivery use of unfractionated heparin in women on therapeutic low-molecular weight heparin British Journal of Haematology. 142: 453-456. PMID 18510687 DOI: 10.1111/j.1365-2141.2008.07198.x  0.32
2008 Austin SK, Starke RD, Lawrie AS, Cohen H, Machin SJ, Mackie IJ. The VWF/ADAMTS13 axis in the antiphospholipid syndrome: ADAMTS13 antibodies and ADAMTS13 dysfunction British Journal of Haematology. 141: 536-544. PMID 18341632 DOI: 10.1111/j.1365-2141.2008.07074.x  0.32
2008 Austin SK, Lambert JR. The JAK2V617F mutation and thrombosis (British Journal of Haematology (2008) 143, (307-320)) British Journal of Haematology. 143: 451. DOI: 10.1111/j.1365-2141.2008.07406.x  0.32
2007 Sukupolvi-Petty S, Austin SK, Purtha WE, Oliphant T, Nybakken GE, Schlesinger JJ, Roehrig JT, Gromowski GD, Barrett AD, Fremont DH, Diamond MS. Type- and subcomplex-specific neutralizing antibodies against domain III of dengue virus type 2 envelope protein recognize adjacent epitopes. Journal of Virology. 81: 12816-26. PMID 17881453 DOI: 10.1128/Jvi.00432-07  0.32
2007 Oliphant T, Nybakken GE, Austin SK, Xu Q, Bramson J, Loeb M, Throsby M, Fremont DH, Pierson TC, Diamond MS. Induction of epitope-specific neutralizing antibodies against West Nile virus. Journal of Virology. 81: 11828-39. PMID 17715236 DOI: 10.1128/Jvi.00643-07  0.32
2006 Gardiner C, Cohen H, Austin SK, Machin SJ, Mackie IJ. Pregnancy loss, tissue factor pathway inhibitor deficiency and resistance to activated protein C Journal of Thrombosis and Haemostasis. 4: 2724-2726. PMID 16959025 DOI: 10.1111/j.1538-7836.2006.02197.x  0.32
2003 Panchapakesan U, Austin SK, Shafransky A, Lawrence JA, Savdie E. Recovery of pure red-cell aplasia secondary to antierythropoietin antibodies after cessation of recombinant human erythropoietin Internal Medicine Journal. 33: 468-471. PMID 14511202 DOI: 10.1046/j.1445-5994.2003.00448.x  0.32
Show low-probability matches.